BCMT Home


About the Firm
Portfolio Companies
News & Events
Contact Us
  Home  
  04/03/2007
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis

 
  03/20/2007
Houston Technology Center Announces $2 Million Award to PLx Pharma Inc., $794,520 Award to Molecular LogiX Inc. by the Texas Emerging Technology Fund

 
  03/19/2007
Opexa Reports Year End 2006 Financial Results

 
  03/01/2007
Kryptiq Applauds Steps to Improve Healthcare Efficiency and Patient–Centered Care

 
  02/14/2007
Opexa Therapeutics Launches Tovaxin™ Clinical Trial Website for Multiple Sclerosis